The workshop, dubbed “Phenylketonuria: Advances and Challenges,” is expected to come out with the Saudi experience spelt out by eminent doctors who are dealing with the disease.

Dr. Zuhair Rahbeeni is slated to make the introductory remarks at the opening of the scientific session chaired by Dr. Ali Al-Mehaidib and Dr. Hamad Al-Zaidan.

During the first session of the workshop, Dr. Nadia Sakati is scheduled to speak on the history of PKU in the Kingdom, while professor Blau Nenad will give an overview on the future trends of the disease.

Phenylketonuria is inherited, which means it is passed down through families. Both parents must pass on the defective gene in order for a baby to have the condition, making it an autosomal recessive trait.

Babies with PKU are missing an enzyme called phenylalanine hydroxylase, which is needed to break down the essential amino acid phenylalanine. The substance is found in foods that contain protein.

Without the enzyme, levels of phenylalanine and two closely related substances build up in the body. These substances are harmful to the central nervous system and cause brain damage.